Bing

First Solar (FSLR) made JPMorgan's short list of stocks to avoid in 2013. In fact, the solar panel maker was the only stock to make the list. That's an unusual move for JPMorgan (JPM), whose equity stock analysts typically pick several stocks to avoid as ...
CNN Money · ByMaureen Farrell · 12/14/2012
Assets are the company’s year-end total. Total stockholders’ equity is the sum of all capital stock, paid-in capital, and retained earnings at the company’s year-end. Excluded is equity attributable to noncontrolling interests. Also excluded is ...
FORTUNE · 6/4/2015
We wish all the best to Aunt Linh. Thanks for quotes from Mary Murcko, Jeannie Mai, Dr. Ann Cabot, SELF®, Biogen(NASDAQ:BIIB), & Reimagine MySelf)
Examiner · 8/20/2015
In the realm of stock performance, some big drugmakers delivered big gains over the first half of the year. Hospira ($HSP), the injectables specialist Pfizer ($PFE) agreed to buy earlier this year for $15 billion, delivered a 42.5% gain for the first half ...
FiercePharma · ByTracy Staton · 7/9/2015
BetterInvesting Magazine Releases October Stock To Study And Undervalued Stock Choices For Investors' Informational And Educational Use PR Newswire MADISON HEIGHTS, Mich., Aug. 7, 2015 "The committee selected Delta Air Lines for its high …
Reuters · 8/7/2015
Since Biogen reported preliminary findings from the BIIB037 trial in December, the stock had gained 41 percent. Investors have awaited the full trial results to gauge whether they back up the initial optimism over the drug’s chances. Chief Executive ...
Bloomberg · ByMakiko Kitamura · 3/20/2015
Well, as we know there are two types of person in the stock market one is trader and another ... We told our members in facebook private group to buy BioCryst Pharmaceuticals, Inc.(NASDAQ:BCRX) yesterday at $14.30. Now look at the price of the stock ...
Market News Call · 6/19/2015
This could mean short sellers are using the stock to hedge a long bet elsewhere, or could also mean that short sellers believe the price of the stock will decline. When short sellers eventually cover their positions, by definition there must be buying ...
Market News Video · 8/13/2015
The average estimate of 19 analysts surveyed by Zacks Investment Research was for earnings of $4.10 per share. But the reduced forecast weighed on the stock. Biogen's shares declined $64.47, or 16.8 percent, to $320.58 in morning trading.
The Miami Herald · 7/24/2015
But it's something most people will go to great lengths to avoid. So let me tell you why you should first calculate these four things every time you buy another stock. What you'll find below is a nearly foolproof way to evaluate the quality and the value ...
Daily Wealth · ByPorter Stansberry · 6/24/2015

Biogen Idec

Company
Biogen is a global biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and deliver…
Biogen is a global biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and delivery of therapies for the treatment of neurodegenerative, hematologic, and autoimmune diseases to patients worldwide.
Data from: Wikipedia · Freebase